Rituximab vs. Tocilizimab for Scleroderma: Which is Better?
Dr. Janet Pope discusses abstract OP0295 presented at Eular 2024 in Vienna, Austria.
https://t.co/70YF2wxwj5 https://t.co/8BHCafFs3u
Links:
Rituximab vs. Tocilizimab for Scleroderma: Which is Better? | RheumNow
https://buff.ly/4cvPLfq
Jun-22-2024
